Before the TB-preventive therapy, the TBI subjects had higher proportion of Mtb-specific CD45RA-CD27+CD4+ T cells and the active-TB higher proportion of Mtb-specific CD45RA-CD27-CD4+ T cells compared to other groups. This evidence concerns the gene CD4 and tuberculosis.